Clinical Trial Update: H. Pylori Eradication for Moderate ITP [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Helicobacter pylori eradication for immune thrombocytopenic purpura (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Immune Thrombocytopenic Purpura

Snippet

Sponsor: Seoul National University Hospital | Conditions: Immune Thrombocytopenic Purpura, Helicobacter Pylori | Phase 3 | Status: UNKNOWN